Ovarian Cancer Therapeutics Market Size, Share & Industry Analysis, By Drug Class (PARP Inhibitors, Platinum-based Chemotherapy, Taxanes, VEGF/Anti-angiogenic Agents, and Antimetabolites), By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, and Hormone Therapy), By Disease Indication (Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Germ Cell Ovarian Tumors, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, and Others), and Regional Forecast, 2026-2034.